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Department of Chemistry, College of Science and Engineering, University of Minnesota, Minneapolis, MinnesotaABSTRACT This study reports how quantal size, or the quantity of chemical messengers within a storage granule, is regulated
in platelet dense-body granules via dynamic adaption of granule size according to changing levels of granule contents. Mech-
anistic studies using carbon-fiber microelectrode fast-scan cyclic voltammetry and amperometry methods correlated with trans-
mission electron microscopy analysis reveal the impact of granule structural changes on granular content secretion kinetics and
highlight the dynamic interplay between soluble granule contents and membrane components in exocytosis. Despite the distinct
chemical profile of platelet dense-body granules, these secretory granules act according to general biochemical/biophysical
phenomena using charge-charge interactions to sequester chemical messengers and employ known conserved exocytotic
machinery to deliver them; therefore, the mechanistic information obtained herein further advances the general understanding
of exocytosis while revealing fundamental details about blood platelets.INTRODUCTIONNature has evolutionarily conserved the SNARE (solu-
ble N-ethylmaleimide-sensitive factor attachment protein
receptor)-based exocytotic machinery to deliver chemically
distinct signaling molecules to the extracellular space for a
broad range of functional purposes (1–3). Outstanding ex-
amples include, but are not limited to, neurotransmitter sec-
retion from neurons (4), insulin secretion from b-cells (5),
and chemical messenger secretion from endocrine (6) and
immune cells (7). Fundamental understanding of exocytosis
has increased tremendously, particularly the temporal and
spatial dynamics of the SNARE machinery and lipid mem-
brane components (8–12); however, the biochemical and
biophysical interplay between the vesicle/granule contents
and membrane components to influence chemical messen-
ger delivery is not yet well understood.
Despite our limited understanding of this interplay,
accumulated evidence suggests that vesicle/granule-driven
dynamics are critical in regulating exocytosis. For instance,
the negatively charged polymeric matrices found in chro-
maffin cell dense-core vesicles (13) and mast cell granules
(14) play a critical role in sequestering positively charged
small soluble chemical species, and even driving the fusion
pore expansion (15). Indeed, the ablation of genes, which
encode these matrix molecules in chromaffin cells, has
a detrimental effect on both the maximal sequestering
capacity of small soluble molecules and their secretion
kinetics (16). In addition, the chemical contents have also
been shown to dynamically regulate the size or volume of
the vesicles/granules where these molecules are stored, a
phenomenon referred to herein as quantal regulation. This
dynamic interplay was first experimentally demonstrated
for catecholamine-laden secretory vesicles in intact cultured
PC12 cells (17), and later, was also observed in isolatedSubmitted August 2, 2011, and accepted for publication October 3, 2011.
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or proteins could be incorporated (18). The large structural
changes following vesicle/granule content loading or deple-
tion generates a large biophysical property change in the
granule membrane, characterized by parameters such as
membrane curvature and tension, and therefore, may di-
rectly impact the membrane fusion kinetics and ultimate
content secretion. Understanding these dynamic interactions
and their influence on membrane fusion kinetics, including
the intermediate fusion pores stability, is a critical step to-
ward achieving a complete understanding of exocytosis.
In this study, we report the quantal regulation phenom-
enon in blood platelets, the cell type well known in the
bloodstream to safeguard our vascular system, and evaluate
the influence of the quantal size change on the ability of
platelets to deliver critical chemical messengers from their
prominent dense-body granules. Although blood platelets,
like other secretory cell types, use SNARE-based exocytotic
machinery to secrete granule contents for blood clotting
purposes (19), their granule chemical profiles (20) are
unique among those well-characterized secretory vesicle/
granules (21–23). One massive difference lies in the fact
that platelets differentially sort protein-based and inorganic/
small molecule chemical messengers into two morpholog-
ically and chemically distinct secretory granules, known
as a-granules and dense-body granules, respectively (24).
Furthermore, dense-body granules do not contain a typical
biopolymer matrix to sequester the concentrated soluble
inorganic/small molecule species. Recently, a unique type
of inorganic polymer known as polyphosphate was discov-
ered in platelet dense-body granules. Comparative studies
have revealed that platelet dense-body granules, in fact,
belong to an evolutionarily conserved class of organelles,
termed ‘‘acidocalcisomes’’ (25). Only recently have the
important functions of this inorganic polymer in blood coag-
ulation and fibrinolysis begun to be discovered. Polyphos-
phate potently mediates blood clotting via the contactdoi: 10.1016/j.bpj.2011.10.001
2352 Ge et al.pathway and also significantly delays fibrinolysis by en-
hancing the activity of a fibrinolytic inhibitor (26,27).
Considering the functional importance and the distinct
chemical profile of platelet dense-body granules, it is of great
interest to understand how this type of secretory granules
sequester chemical messengers and evaluate the impact of
variations in dense-body granule size on chemical content
delivery. Furthermore, by identifying the common and con-
trasting the difference between platelets and other well-
studied secretory cell models, a better understanding of
quantal regulation phenomena and exocytosis in general
can be achieved.EXPERIMENTAL SECTION
Preparation of washed rabbit platelets
Rabbit platelets were used herein as a secretory cell model because rabbit
platelets contain the largest amount of serotonin among human and animal
species reported previously (28) and characterized in this lab (human,
rabbit, mouse, and rat, data not shown), which greatly facilitates the inves-
tigation of platelet quantal secretion behavior. The procedure to prepare
washed rabbit platelets was adapted from a previously published protocol
for human platelets (29).Transmission electron microscopy studies
The procedure for preparation of Epon-embedded platelet samples for elec-
tron microscopy studies has been published previously (30). Herein, the
uranyl acetate and lead citrate staining used in a typical electron microscopy
preparation to enhance contrast is omitted to minimize possible distur-
bances when evaluating the morphology of the chemically labile dense-
body granule contents.Electrochemical measurements of serotonin
release from platelet suspensions and single
platelets
The procedures for the electrochemical measurements of serotonin release
in platelet suspensions and from single platelets have been published previ-
ously (29,30). All experiments were performed at room temperature and in
the absence of extracellular Ca2þ. Human thrombin was used to activate
rabbit platelets, and its saturating dosage of 4 U/mL was determined inde-
pendently based on the maximal response of platelet release action under
increasing doses of human thrombin (data not shown).Data analysis
For transmission electron microscopy (TEM) studies, the diameters of
granules and the associated dense-body cores were measured in Image J
software (National Institutes of Health, Bethesda, MD) by averaging the
perpendicular short and long axes. Given the Gaussian distribution of
granule and core sizes, data points were considered outliers according to
the 1.5 interquantile range criteria. Outliers are those data points that
fall>1.5 the interquantile range below the first quantile or above the third
quantile. The outlier exclusion procedure was repeated until no additional
outliers were identified. In addition, the underestimation of true granule
and core sizes using a 60-nm-thick thin section to measure >150-nm-
diameter granules and cores was corrected based on a previously published
model (31). Because this model only corrects for the average values of
granule and core sizes, their true sizes were approximated by simply scalingBiophysical Journal 101(10) 2351–2359up the individually measured sizes using the average-based correction ratio
calculated from the model. The data analyses for platelet suspension and
single platelet experiments followed the previously published procedures
(12,30). In addition, the 1.5 interquantile range criteria were also applied
to the logarithmically transformed amperometric data given their non-
Gaussian distribution nature. The number of repeated measurements, plate-
lets, or secretion events is indicated for each data set. The number may
appear as a range for different parameters in the same experiment resulting
from the outlier exclusion criteria outlined above. All data are represented
as mean 5 SEM if not otherwise indicated, and subject to the non-
paired, two-tailed Student’s t-test. Statistical difference was affirmed
when p < 0.05.RESULTS
Dense-body granule size change following
reserpine and serotonin treatments
Platelets do not have the capacity to synthesize serotonin;
instead they take up serotonin directly from the bloodstream
(20). To manipulate platelet serotonin levels, washed plate-
lets were treated with serotonin and reserpine, a drug known
to deplete monoamines from secretory vesicles/granules
(32). Following treatments, the microstructural changes in
platelet dense-body granules were evaluated by TEM. Anal-
ogous to dense-core vesicles in PC12 cells (17), dense-body
granules in platelets exhibit two subcompartments within
the granule lumen, i.e., the opaque core and translucent
halo region (Fig. 1, A–C), and the core occupies only a frac-
tion of the overall granule volume. Under control condi-
tions, electron microscopy analysis indicates that the core
is 3.4 5 0.1 aL and the halo is 8.0 5 0.3 aL (mean 5
SEM), indicating dual storage sites for granule contents.
The core size decreased significantly when platelets were
treated with reserpine (see Fig. 1 E); however, it maintained
the same dimension under serotonin treatment conditions.
The overall granule diameter changed significantly (p <
0.05) under both conditions (Fig. 1 D); however, the granule
volume only increased under serotonin treatment conditions
(p< 0.001, Fig. 1 E). Comparative analysis of the calculated
volumes suggests that the increased granule volume under
serotonin treatment conditions stems primarily from ex-
panded halo volume.Serotonin release in platelet suspensions
Following reserpine and serotonin treatments, the overall
quantity and rate of thrombin-stimulated serotonin release
from platelet suspensions were determined using ensemble
fast-scan cyclic voltammetry (29). A carbon-fiber micro-
electrode was directly immersed in a platelet suspension
and the voltage on the electrode was repeatedly swept to
oxidize/reduce serotonin and thus measure the extracellular
serotonin. Thrombin, a physiological stimulant, was used to
activate the platelets and initiate exocytosis. Fig. 2 A shows
typical traces of serotonin release from platelet suspensions
stimulated with a saturating thrombin dose of 4 U/mL. The
FIGURE 1 Dense-body granule size change evaluated by TEM. (A–C)
Representative thin section electron micrographs of platelets treated with
reserpine or serotonin. Scale bars in insets, 200 nm. (D and E) The
measured size distributions of core and granule, and the calculated volumes
of core, halo, and granule in these treated platelets. To improve clarity, the
core distribution for the control condition was left shifted by 4 nm. Granule
size changes are both significant for reserpine (p< 0.05) and serotonin (p<
0.01 versus control) treatment conditions compared to control, and core size
change is only significant (p < 0.001) for reserpine condition compared to
control. The halo volume is defined as the translucent space between the
granule membrane and core as illustrated in D. The number of measured
dense-body granules is 477, 483, and 452 for reserpine, control, and sero-
tonin conditions, respectively. ***p < 0.001 versus control using the
Student’s t-test.
Quantal Regulation in Platelets 2353molecular identity of the released serotonin was confirmed
by comparing the measured cyclic voltammogram to that
of a standard solution (Fig. 2 B). The small background
current increase caused by thrombin addition conveniently
indicates the onset of activation. After an ~10 s delay, the
release of serotonin starts and continues for ~1 min before
it reaches a plateau. The occasional sharp current spikes
on the release trace are those dense-body granules secreting
serotonin immediately adjacent to the electrode surface.
Reserpine treatments expectedly decreased the maximal
released serotonin; however, no change of released sero-
tonin quantity was observed for serotonin treatment condi-
tions, indicating that the stored serotonin contents in
control rabbit platelets approach their maximal storage
capacity. Based on the rate of serotonin release charac-
terized by the Tdelay and T10–90% (Fig. 2, C–E), the over-
all release kinetics of these drug-treated platelets is,
however, not compromised, suggesting that the measured
decrease in serotonin release is caused by the altered
amount of serotonin stored per granule, viz., decreased
quantal size.Serotonin secretion from individual dense-body
granules
The drug-induced microstructural changes and quantal size
alteration prompted real-time examination of quantal secre-
tion from dense-body granules using the single-cell carbon-
fiber microelectrode amperometry method. Fig. 3 A shows
a typical amperometric trace measured from a single platelet
activated by thrombin. Due to the low number of dense-
body granules contained in small platelets (~3 mm in diam-
eter), virtually all spikes are baseline resolved and well
separated, a clear advantage over other larger secretory
cell models with hundreds or thousands of vesicles/granules
(33). Cumulative occurrence of spikes measured from three
conditions reveals virtually the same time courses of quantal
secretion (Fig. 3 B), consistent with the kinetic data shown
in Fig. 2 E.
Analysis of the amperometric spikes reveals rich informa-
tion about the platelet quantal secretion kinetics of individual
dense-body granules and their variations under reserpine
and serotonin treatment conditions. First, as expected, the
quantal size decreased significantly under reserpine condi-
tions and increased under serotonin conditions, though not
significantly (Fig. 3 D). The overall trend is in line with the
results obtained by ensemble fast-scan cyclic voltammetry
measurements (Fig. 2D) and, in fact, correlates strongly (cor-
relation coefficient 0.91), confirming the expected effects
of these treatments. Similarly, both the estimated granular
serotonin concentration (Fig. 3 E) and the average spike
current amplitude (Fig. 3 F) show strong correlation with
the quantal size, with correlation coefficients of 0.98 and
0.94, respectively; however, the kinetic parameters Trise
andT1/2, which characterize the early stages of themembrane
fusion process immediately following the fusion pore
opening, correlate poorly to the quantal size with correlation
coefficients of 0.55 and 0.63, respectively. The poor correla-
tion suggests that the time course of the early serotonin efflux
is likely modulated by factors other than the overall amount
of granule contents. On the basis of the morphologically
evident dual-subcompartments (Fig. 1, A–C), and thus, two
likely distinct pools of serotonin molecules in the granule
lumen, the correlation between kinetic parameters and
halo/core volumes was further examined. Indeed, Trise and
T1/2 correlate strongly with the halo volume (Fig. 1 E),
with correlation coefficients of 0.99 and 0.98, respectively.
Tdecay also correlates strongly with the core volume (Fig. 1 E)
with a correlation coefficient of 0.91. These strong covaria-
tions suggest that the subcompartment volumes of the core
and halo in platelets are critical factors in controlling the
time course of serotonin release from these secretory granules.Serotonin secretion through fusion pores
The typical foot feature (34) commonly observed in am-
perometric measurements (see Fig. 4 D) is caused by theBiophysical Journal 101(10) 2351–2359
FIGURE 2 Serotonin release from platelet suspensions. (A) Representative serotonin release traces measured from thrombin-stimulated platelet suspen-
sions (5.0  106 platelet/mL). Final thrombin concentration is 4 U/mL. The dotted line represents the shifted baseline upon thrombin addition. (B) The
reconstructed cyclic voltammogram at 150 s (marked by a circle in A) for the control condition is compared to that of a standard serotonin solution (dotted
line). (C) Release trace analysis includes the determination of Tdelay, T10–90%, and [Serotonin]max. (D and E) Drug effects on serotonin release kinetics from
treated platelet suspensions. N ¼ 3 except N ¼ 2 for control condition in T10–90%, **p < 0.01 versus control using the Student’s t-test.
2354 Ge et al.restricted efflux of stored molecules and is thought to reflect
the dynamics of short-lived fusion pore intermediates before
full membrane fusion and massive content release (35).
Reported foot features (36–39) from other secretory cell
models have also been observed in platelets (Fig. 4 B),
despite varying appearance and degrees of occurrence.
The upper two amperometric traces in Fig. 4 B represent
the majority of the observed foot features. They are typically
characterized by an ascending current phase alone or with
an additional plateau region ahead of a full fusion spike.
Much finer features are also observed occasionally on top
of a typical foot feature, such as minor current flickers or
an often less-pronounced second ascending phase between
the plateau and rapid rising phase of the full fusion spike.
In addition to these typical foot features, the lower two
traces in Fig. 4 B represent two rarely observed foot features
(<1%) that may represent one distinct mode of exocytosis,
known as kiss-and-run (40). In this mode of exocytosis,
secretory granules fuse and, immediately or after a short
period of time, retreat and close the fusion pore, resulting
in a pulsed release of granule contents measured as a
reduced-sized amperometric spike or a stand-alone foot.
One stand alone foot feature is readily evident in the bottom
trace. Its sharp current flickers indicate the dynamic nature
of the fusion pore, whereas the nearly rectangularly shaped
current profile indicates the relative stability of the formed
fusion pore over ~100 ms; the semi-stand-alone foot feature
on the other trace likely represents a failed kiss-and-run
exocytosis event due to incomplete fusion pore closure after
the attempted granule retreat. Despite the apparent diversity
in foot features, the average occurrence of spikes with typical
foot features was maintained at ~50% for all three plateletBiophysical Journal 101(10) 2351–2359treatment conditions and did not change significantly (data
not shown). In addition, the temporal evolution of foot fea-
tures appears to be a random process as the release of gran-
ules with observable fusion pores is not temporally biased
(Fig. 4 C). Though the reported traces were plotted using
pooled secretion events from all three conditions, similar
results were observed under each condition.
Structural changes in dense-body granules and altered
quantal size do appear to alter the kinetics of serotonin
release through the fusion pore. The foot parameters in-
cluding Tfoot, Ifoot, and Qfoot (Fig. 4 D), all displayed rising
trends with the increasing granule or quantal sizes (Fig. 4,
E–G). Under reserpine conditions, both foot duration and
maximum foot current amplitude decreased mildly though
not in a statistically significant manner; however, the foot
area decreased significantly. Instead, for the serotonin con-
dition, despite the small increase in foot area, both foot
duration and maximum foot amplitude increased signifi-
cantly. It is noteworthy that foot area is proportionally
reduced when the quantal size decreased or increased, and
equally ~7% of the overall released serotonin content was
liberated via the fusion pores under all three conditions. In
addition, the trend in Tfoot values (Fig. 4 E) is consistent
with Trise (Fig. 3 G) and T1/2 values (Fig. 3 H) under the
same treatment conditions, suggesting a strong positive
correlation between fusion pore stability and membrane un-
folding kinetics in the early full fusion phase.DISCUSSION
Biochemical studies (19,41–43) have revealed that platelet
dense-body granules, and in fact, coexisting a-granules,
FIGURE 3 Platelet quantal secretion. (A) A representative amperometric trace measured from a thrombin-activated platelet. Thrombin concentration is
4 U/mL. (B) Cumulative occurrence of measured current spikes over time. The number of spikes is 147, 208, and 191 for reserpine, control and serotonin
conditions, respectively. (C) Amperometric spike analysis includes the determination of spike current I, spike area Q, rise time, T1/2, and decay time. (D–I)
Drug effects on the quantal secretion kinetics. In E, the quantal size (left y axis) or the converted number of serotonin molecules (right y axis) is plotted
against the independently determined granule volume. The calculated nominal granular serotonin concentrations are labeled. Straight lines are drawn to visu-
ally indicate the nominal concentrations that equal to the slopes of the lines. All data are represented as mean5 SEM. N¼ 16 ~ 19, N¼ 20, and N¼ 12 ~ 16
platelets for reserpine, control, and serotonin conditions, respectively. *p < 0.05 versus control using the Student’s t-test.
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to deliver their granule contents. Dense-body granules, how-
ever, represent a less-understood class of platelet secretory
granules, especially regarding the biochemical and biophys-
ical behavior of the granule contents and the dynamic nature
of granule content secretion. Platelet dense-body granules
store and release primarily ions and small molecules such
as the clotting stimulant ADP for hemostasis and thrombosis
purposes. Historically, due to the small size of platelets,
electron microscopy has been the tool of choice to investi-
gate platelet secretory behaviors (24); however, unlike the
availability of a rich literature regarding the protein secre-
tion from a-granules, such as its unusual secretion pathway
through the platelet membrane structure known as the open
canalicular systems (44), sparingly few parallel studies exist
for dense-body granule secretion. The technical difficulty in
fixing dense-body granule contents during secretion forelectron microscopic studies is largely due to the labile
nature of the inorganic granular species; therefore, their
dynamic secretory behavior is poorly understood. As a
result, the chemical basis for platelet dense-body storage re-
mains elusive. Secretory granule scaffold molecules (13,14)
are commonly highly charged biopolymers, serving as a
matrix to sequester ions and small molecules, and thus
reduce the effective intraganular osmolarity. Because no
scaffold-type species is known to exist in platelet dense-
body granules, a storage mechanism based on small-mole-
cule aggregation has been proposed (45). This matrix-free
storage mechanism is challenged by the recent discovery
of the inorganic polymer material polyphosphate in platelet
dense-body granules (25). The reported platelet polyphos-
phate is a short, linear chain inorganic polymer with 70–75
repeating phosphate units (25). Despite the acidic con-
ditions within the granule lumen (pH ~5.5), polyphosphateBiophysical Journal 101(10) 2351–2359
FIGURE 4 Fusion pores in platelet quantal secretion. (A) A representative amperometric trace where spikes exhibiting foot features are marked. (B) The
appearance of observed foot features. The relative occurrence is indicated. The upper and lower scale bars apply to the top and bottom two traces, respec-
tively. (C) The cumulative occurrence of measured spikes with and without foot features over time. (D) Amperometric foot analysis includes the determi-
nation of foot area Qfoot, foot threshold Ifoot, and foot duration Tfoot. (E–G) Drug effects on the amperometric foot kinetics. N¼ 59 ~ 60, 90 ~ 97, 80 ~ 81 foot
features for reserpine, control, and serotonin conditions, respectively. *p < 0.05 versus control using the Student’s t-test.
2356 Ge et al.is still a highly charged polyanion due to its strongly acidic
nature (46), and thus likely acts as a matrix, much like ion
exchange resin, to sequester positively charged chemical
species principally via charge-charge interactions. Interest-
ingly, based on the ancient history of this molecular fossil
(47), polyphosphate has been hypothesized to provide a
template for guided assembly of macromolecules via similar
charge-charge interaction principles in prebiotic evolution.
TEM results obtained herein for platelet dense-body
granules revealed morphological changes in vesicles/gran-
ules when stored chemical contents are altered consistent
with those reported previously for other secretory vesicles.
Dense-core vesicles in PC12 cells displayed granule size
expansion and halo volume increase when excess catechol-
amine was synthesized in the cytoplasm and loaded into the
vesicles (17). Glutamatergic vesicles isolated from brain
tissues were also observed to expand their volume to accom-
modate newly imported glutamate (18). Patch-amperometry
studies of dense-core vesicles in chromaffin cells further
indicate such behavior when excess catecholamine mole-
cules are incorporated (48). These consistent experimental
observations suggest that the dynamic size change of secre-
tory vesicle/granule in response to changing levels of stored
chemical contents is likely a general cellular feature for
secretory cells. The concomitant changes in granule volume
and quantal size suggest a shared regulation mechanism
used by these different secretory cells to maintain constant
vesicular/granular chemical messenger concentration forBiophysical Journal 101(10) 2351–2359physiological purposes, and in fact, estimated vesicular/
granular concentration was relatively constant in the afore-
mentioned secretory cells. However, it is unclear if this
dynamic behavior would be possible in anuclear platelets
with their distinct inorganic granular matrix. Experimental
results reported herein for platelets (Fig. 3 E) appear to
support this hypothesis under serotonin treatment condi-
tions; however, an appreciably lower concentration (versus
control, Fig. 3 E) is estimated for reserpine conditions,
suggesting a subtle difference between platelets and other
secretory cells and perhaps also a less dynamic nature for
platelet dense-body granules.
Although the large structural change caused by the phys-
ical expansion of the secretory granules upon serotonin
incubation can be experimentally observed, its implication
for membrane fusion and content release is unclear. It is
commonly accepted that lipid-dominant vesicles are fairly
rigid and achieve only limited physical expansion (~4%,
membrane area-based) before tension-induced membrane
rupture (49). To accommodate the large structural change
beyond the estimated physically allowed limit, cellular
mechanisms must have evolved to achieve this goal. Inter-
granule fusion and de novo lipid or protein synthesis and
incorporation are two possible candidates to reduce the
otherwise high membrane tension. The same number of
granules measured per platelets under all three conditions
(data not shown) suggests intergranule fusion is not a likely
option. Additionally, platelets are an anuclear cell type, and
Quantal Regulation in Platelets 2357have limited capability for de novo synthesis (50). There-
fore, unless explained by other unidentified means, the large
structural change (~10% increase in granule surface area
based on granule size data in Fig. 1 D) must, unexpectedly,
be physically tolerated by platelet dense-body granules.
Indeed, the observed reversible size change of isolated glu-
tamatergic vesicle in vitro suggests this is possible (18). If
true, one might expect that the large structural change would
inevitably lead to altered biophysical properties of the
granule membrane which, in turn, would influence the
secretion of granule contents. Experimental results herein
clearly show a significant impact on serotonin secretion
arising from such large structural change and highlight the
important interplay between granule content and mem-
brane dynamics. To ensure that the observed change in
quantal secretion kinetics is attributable to the large struc-
tural change, rather than other unidentified compensatory
responses in treated platelets, functional assessments of
platelet suspension release behavior confirmed that the over-
all ability of platelets to deliver dense-body granules is not
compromised. The assessment further suggests an exclusive
quantal size change in dense-body granules under these
conditions and, in fact, was confirmed in the presented sin-
gle platelet studies. More importantly, the large alteration in
secretion kinetics revealed by single platelet studies strongly
suggest that the biophysical properties of the secretory gran-
ules play an important role in regulating membrane fusion
and ensuing content secretion. On the basis of the obvious
changes in membrane curvature and membrane tension
accompanying the large structural change, we examined
whether membrane curvature and membrane tension could
be two biophysical factors accounting for the observed vari-
ations in quantal secretion kinetics.
Although the average size of dense-body granules
changes following drug treatments, and the membrane cur-
vature of granules (1/R) appears to correlate with the unfold-
ing membrane dynamics of fusing granules characterized by
Trise and T1/2, a more reliable analysis using much wider size
distribution of the granules under each condition reveals
a weak correlation between membrane curvature, repre-
sented by 1/Q1/3 and Trise or T1/2, with an absolute correla-
tion coefficient of<0.29 for all three conditions. Q1/3, which
is linearly proportional to the granule radius (51), was used
herein to estimate the membrane curvature as the accurate
determination of the granule size for each amperometrically
measured secretion events is currently impractical for small-
sized platelets (35). The calculated low correlation coeffi-
cient indicates a weak influence of membrane curvature on
the membrane unfolding dynamics characterized by Trise or
T1/2. Parallel analysis of the foot duration Tfoot and mem-
brane curvature reveals a similar weak correlation, with an
absolute correlation coefficient <0.48 under all three condi-
tions. The observed poor correlation suggests that mem-
brane curvature is a weak factor in regulating the stability
of fusion pores or ensuing membrane unfolding dynamics.Membrane tension is another immediately relevant factor;
however, it is difficult to experimentally address and theo-
retically relate the energetic contribution from membrane
tension to measured amperometric secretion events. Never-
theless, the experimental results suggest that increased
membrane tension plays a role in stabilizing the fusion
pore structure as characterized by longer fusion pore main-
tenance (Fig. 4 E), assuming that granules indeed experi-
ence an increase in expansion-induced membrane tension.
In fact, similar experimental results were reported for
PC12 cells (37). However, it is noteworthy that opposite ex-
perimental results were observed for chromaffin cells (52),
which have similarly sized dense-core vesicles to those
found in platelets. It is unclear, solely based on ampero-
metric measurements, what factors could have caused the
discrepancy. Indeed, a variety of factors have been reported
to alter the short-lived and delicately balanced fusion pore
structure (53). Given the distinct chemical profiles and
possible different biophysical behaviors of vesicle/granule
contents, further studies are required to reconcile these
observations and provide a clear picture of the interplay
between granule contents and membrane fusion. Neverthe-
less, it is evident that the volumes of the halo and core
regions are critical physical factors in determining the
quantal secretion kinetics on the basis of the strong linear
dependence of Trise and T1/2 on the halo volume and Tdecay
on the core volume. Presumably, the more fluidic serotonin
content in the halo volume is preferentially released first,
followed by slow release of the less mobile serotonin con-
tent sequestered in the polyphosphate matrix (5,37,38,54).
Together, these results suggest that the interplay of mem-
brane dynamics and the amount and biophysical states of
serotonin within the halo and core subcompartments deter-
mine the ultimate time course of quantal secretion in platelet
dense-body granules. It is possible that similar principles
govern the behavior of granule content delivery in general
for secretory vesicles/granules that display dual-storage
subcompartments.
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